KIMS Hospitals Financial Highlights and ESG Initiatives
KIMS
HOSPITALSTM
Financial & Operational Highlights - 1/2
(Rupees in Millions)
FINANCIAL
HIGHLIGHTS
Q3 FY 23 Consolidated
• From 1st September 22, M/s SPANV Medisearch Lifesciences Private Limited (Kingsway Hospital, Nagpur) has become subsidiary
of "KIMS Hospitals", post-acquisition of 51% stake. Therefore, Q3 FY23 includes 3 months performance whereas Q2 FY23
includes only 1 month performance of Nagpur unit.
• Key financial figures Ex. Nagpur unit are provided for better QoQ comparison. [Adjusted EBITDA margin improved by 0.1% to
27.2% on QoQ basis]
Consolidated
Nagpur
Consolidated Ex. Nagpur
Particulars
Q3 FY 23
Q2 FY 23
Q3 FY 22
QoQ
YoY
Q3 FY23
Q2 FY23 #
Q3 FY 23
Q2 FY 23
QoQ
YoY
Total Income
5,686.1
5,732.8
3,959.6
372.5
143.2
5,313.7
5,589.6
Less Other Income
64.5
92.0
23.9
1.2
0.6
63.3
91.5
Revenue from Operations
5,621.6
5,640.7
3,935.7
-0.3%
42.8%
371.2
142.6
5,250.4
5,498.1
-4.5%
33.4%
PBT
1,128.2
1,226.3
1,103.8
-8.0%
2.2%
-80.7
-25.7
1,208.8
1,252.0
-3.5%
9.5%
Add Interest
115.2
78.8
29.7
60.0
23.5
55.3
55.3
Add Depreciation
332.9
311.2
188.1
37.2
16.7
295.7
294.5
Reported EBITDA (Including other income) as
per Financials
1,576.3
1,616.3
1,321.5
-2.5%
19.3%
16.5
14.5
1,559.8
1,601.8
-2.6%
18.0%
Less Other Income
64.5
92.0
23.9
1.2
0.6
63.3
91.5
Less INDAS 116
67.9
77.3
8.2
67.9
77.3
EBITDA Pre INDAS & Other Income
1,444.0
1,447.0
1,289.4
-0.2%
12.0%
15.3
14.0
1,428.7
1,433.0
-0.3%
10.8%
EBITDA % to Revenue from Operations
Add: One off Old Luxury Tax Settlement
25.7%
25.7%
32.8%
4.1%
9.8%
27.2%
26.1%
54.9
54.9
Add: One off Expenses in Q3 (Nagpur)
Adjusted EBITDA
26.1
26.1
1,470.1
1,501.9
1,289.4
-2.1%
14.0%
41.4
14.0
1,428.7
1,487.9
-4.0%
10.8%
Adjusted EBITDA %
26.2%
26.6%
32.8%
11.1%
9.8%
27.2%
27.1%
#Q2 FY23 represents 1 month (Sep '22) performance
Private & Confidential
14View entire presentation